BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21344376)

  • 21. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
    Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
    Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
    Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
    Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonality of cutaneous melanoma diagnosis in Northern Ireland with a review.
    Chaillol I; Boniol M; Middleton R; Doré JF; Autier P; Gavin A
    Melanoma Res; 2011 Apr; 21(2):144-51. PubMed ID: 21317819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
    Robsahm TE; Bergva G; Hestvik UE; Møller B
    Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
    Whiteman DC; Bray CA; Siskind V; Green AC; Hole DJ; Mackie RM
    Eur J Cancer Prev; 2008 Jun; 17(3):243-50. PubMed ID: 18414196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States.
    Watson M; Geller AC; Tucker MA; Guy GP; Weinstock MA
    Prev Med; 2016 Oct; 91():294-298. PubMed ID: 27565055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.
    Whiteman DC; Green AC; Olsen CM
    J Invest Dermatol; 2016 Jun; 136(6):1161-1171. PubMed ID: 26902923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stage distribution of malignant melanomas in a Hungarian centre].
    Tóth V; Somlai B; Hársing J; Hatvani Z; Kárpáti S
    Orv Hetil; 2013 Jun; 154(25):969-76. PubMed ID: 23774804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are all melanomas dangerous?
    Nørgaard C; Glud M; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):499-503. PubMed ID: 21874217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
    Boniol M; Armstrong BK; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent incidence trends imply a nonmetastasizing form of invasive melanoma.
    Burton RC; Armstrong BK
    Melanoma Res; 1994 Apr; 4(2):107-13. PubMed ID: 8069096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of malignant melanoma--lessons to be learned from Austria.
    Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
    Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.